Intensive blood pressure lowering helped reduce the risk of mild cognitive impairment (MCI), according to a substudy from the SPRINT trial presented last week at the Alzheimer’s Association International Conference in Chicago.

Patients who undergo coronary artery bypass grafting (CABG) have shorter operations, fewer complications and better survival rates if they have surgeons who are subspecialized in CABG, researchers report in The Annals of Thoracic Surgery.

Siemens Healthineers received FDA approval of its High-Sensitivity Troponin I assays (TnIH)1 for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The new troponin assays will allow physicians to correctly diagnose patients for acute myocardial infarction (MI).

Depressive patients who took escitalopram after acute coronary syndrome (ACS)-related events had lower reoccurrences of major adverse cardiac events after eight years of follow-up, a group of Korean researchers reported in the Journal of the American Heart Association.

Abbott announced it will conduct a pivotal clinical study in the U.S. of its Tendyne Transcatheter Mitral Valve Replacement (TMVR) system, for the treatment of mitral regurgitation (MR).

Twice as many U.S. deaths due to cardiac amyloidosis were reported in 2015 than in 1979, but a study in JAMA Cardiology suggests the disease remains vastly underdiagnosed.

Australian women with the deadliest type of heart attack, ST-segment elevation myocardial infarction (STEMI), are less likely to receive invasive treatment, revascularization or preventive medication at discharge, researchers reported in the Medical Journal of Australia.

A calcium-channel blocker delivered as a nasal spray rapidly restored individuals with paroxysmal supraventricular tachycardia (SVT) to normal sinus rhythm in a phase 2 study, raising the possibility that the drug could be self-administered in a real-world setting and prevent trips to the emergency department.